1.Pretreatment of normal responders in fresh in vitro fertilization cycles: A comparison of transdermal estradiol and oral contraceptive pills.
Nigel PEREIRA ; Allison C PETRINI ; Zhen N ZHOU ; Jovana P LEKOVICH ; Isaac KLIGMAN ; Zev ROSENWAKS
Clinical and Experimental Reproductive Medicine 2016;43(4):228-232
OBJECTIVE: The aim of this study was to investigate the impact of pretreatment with transdermal estradiol (E₂) compared to oral contraceptive pills (OCPs) on controlled ovarian stimulation (COS) response in normal responders undergoing fresh in vitro fertilization (IVF)-embryo transfer (ET) cycles. METHODS: A retrospective cohort study was performed of normal responders undergoing fresh IVF-ET cycles who received pretreatment with transdermal E₂ versus OCPs prior to fresh IVF-ET. The total days of ovarian stimulation, total dosage of gonadotropins, total number of oocytes, and mature oocytes retrieved were noted. Pregnancy outcomes after ET were also recorded. RESULTS: A total of 2,092 patients met the inclusion criteria: 1,057 and 1,035 patients in the transdermal E₂ and OCP groups, respectively. Patients in the OCP group had a longer duration of COS (10.7±1.63 days, p<0.01) than the E₂ group (9.92±1.94 days). Patients in the OCP group also required higher cumulative doses of gonadotropins (2,657.3±1,187.9 IU) than those in the E₂ group (2,550.1±1,270.2 IU, p=0.002). No statistically significant differences were found in the total and mature oocytes retrieved or in the rates of biochemical pregnancy, clinical pregnancy, spontaneous miscarriage, and live birth between the groups. CONCLUSION: Our findings suggest that compared to OCPs, pretreatment with transdermal E₂ is associated with a shorter duration of ovarian stimulation and lower gonadotropin utilization, without compromising the oocyte yield or pregnancy outcomes in normal-responder patients undergoing fresh IVF.
Abortion, Spontaneous
;
Cohort Studies
;
Contraceptives, Oral, Combined
;
Estradiol*
;
Female
;
Fertilization in Vitro*
;
Gonadotropins
;
Humans
;
In Vitro Techniques*
;
Live Birth
;
Oocytes
;
Ovulation Induction
;
Pregnancy
;
Pregnancy Outcome
;
Reproductive Techniques, Assisted
;
Retrospective Studies
;
Superovulation
;
Transdermal Patch
2.Improved Serum Leptin and Ghrelin Following Bariatric Surgery Predict Better Postoperative Cognitive Function.
Michael L ALOSCO ; Mary Beth SPITZNAGEL ; Gladys STRAIN ; Michael DEVLIN ; Ronald COHEN ; Ross D CROSBY ; James E MITCHELL ; John GUNSTAD
Journal of Clinical Neurology 2015;11(1):48-56
BACKGROUND AND PURPOSE: Bariatric surgery is associated with improved cognitive function, but the mechanisms underlying these gains remain poorly understood. Disturbed leptin and ghrelin systems are common in obese individuals and are associated with impaired cognitive function in other samples. Bariatric surgery has been shown to improve serum leptin and ghrelin levels, and these changes may underlie postoperative cognitive improvements. METHODS: Eighty-four patients completed a computerized cognitive test battery prior to bariatric surgery and at 12 months postoperatively. Participants also submitted to an 8-hour fasting blood draw to quantify serum leptin and ghrelin concentrations at these same time points. RESULTS: Baseline cognitive impairments and disturbed leptin and ghrelin levels improved at the 12-month follow-up compared to presurgery. Higher leptin levels were associated with worse attention/executive function at baseline; no such findings emerged for ghrelin. Regression analyses controlling for baseline factors and demographic characteristics showed that both decreased leptin and increased ghrelin following surgery was associated with better attention/executive function at the 12-month follow-up. These effects diminished after controlling for the postoperative change in body mass index (BMI); however, BMI change did not predict 12-month cognitive function. CONCLUSIONS: Improvements in leptin and ghrelin levels following bariatric surgery appear to contribute to postoperative cognitive benefits. These gains may involve multiple mechanisms, such as reduced inflammation and improved glycemic control. Future studies that employ neuroimaging are needed to clarify the underlying mechanisms and determine whether the effects of bariatric surgery on leptin and ghrelin levels can attenuate adverse brain changes and/or risk of dementia in severely obese individuals.
Bariatric Surgery*
;
Body Mass Index
;
Brain
;
Dementia
;
Fasting
;
Follow-Up Studies
;
Ghrelin*
;
Humans
;
Inflammation
;
Leptin*
;
Neuroimaging
;
Obesity
3.Dual role of lipids for genome stability and pluripotency facilitates full potency of mouse embryonic stem cells.
Liangwen ZHONG ; Miriam GORDILLO ; Xingyi WANG ; Yiren QIN ; Yuanyuan HUANG ; Alexey SOSHNEV ; Ritu KUMAR ; Gouri NANJANGUD ; Daylon JAMES ; C DAVID ALLIS ; Todd EVANS ; Bryce CAREY ; Duancheng WEN
Protein & Cell 2023;14(8):591-602
While Mek1/2 and Gsk3β inhibition ("2i") supports the maintenance of murine embryonic stem cells (ESCs) in a homogenous naïve state, prolonged culture in 2i results in aneuploidy and DNA hypomethylation that impairs developmental potential. Additionally, 2i fails to support derivation and culture of fully potent female ESCs. Here we find that mouse ESCs cultured in 2i/LIF supplemented with lipid-rich albumin (AlbuMAX) undergo pluripotency transition yet maintain genomic stability and full potency over long-term culture. Mechanistically, lipids in AlbuMAX impact intracellular metabolism including nucleotide biosynthesis, lipid biogenesis, and TCA cycle intermediates, with enhanced expression of DNMT3s that prevent DNA hypomethylation. Lipids induce a formative-like pluripotent state through direct stimulation of Erk2 phosphorylation, which also alleviates X chromosome loss in female ESCs. Importantly, both male and female "all-ESC" mice can be generated from de novo derived ESCs using AlbuMAX-based media. Our findings underscore the importance of lipids to pluripotency and link nutrient cues to genome integrity in early development.
Male
;
Animals
;
Female
;
Mice
;
Mouse Embryonic Stem Cells
;
Embryonic Stem Cells
;
Genomic Instability
;
Lipids
;
DNA/metabolism*
;
Cell Differentiation